F
ELV icon

FolioMetrix’s Elevance Health ELV Stock Holding History

FolioMetrix’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$481K Hold
3,400
– – 0.2% 102
2015
Q1 		$525K Buy
+3,400
New +$484K 0.27% 82

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

FolioMetrix's ELV Position: Q2 2015 in Review

FolioMetrix held its Elevance Health (ELV) position steady in Q2 2015 at 3,400 shares worth $481K. The position accounts for 0.2% of the portfolio, ranked #102.

FolioMetrix first reported a position in ELV in Q1 2015 and has held it in 2 quarters since. The position peaked at $525K in Q1 2015. 782 funds tracked by Wall St. Rank hold ELV as of Q2 2015.

  • FolioMetrix held 3,400 shares of Elevance Health worth $481K as of Q2 2015.
  • FolioMetrix left its Elevance Health share count unchanged in Q2 2015.
  • Elevance Health made up 0.2% of FolioMetrix's portfolio in Q2 2015, its #102 holding.
  • FolioMetrix first reported a position in Elevance Health in Q1 2015 and has held it in 2 quarters since.
  • FolioMetrix's Elevance Health position peaked at $525K in Q1 2015.
  • 782 funds tracked by Wall St. Rank held Elevance Health as of Q2 2015.

Based on FolioMetrix's 13F filing for Q2 2015, filed 5 Aug 2015.